XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.90%43.45M | 9.28%11.34M | 4.21%10.93M | 4.96%10.68M | -6.11%10.5M | 4.83%42.22M | -6.05%10.38M | -0.45%10.48M | 6.03%10.18M | 22.89%11.18M |
Net interest income | 3.65%35.79M | 10.29%9.41M | 6.80%9.1M | 4.00%8.63M | -6.45%8.59M | 6.82%34.53M | -6.23%8.53M | -1.55%8.52M | 8.84%8.3M | 32.14%9.18M |
-Net interest income | 15.90%50.47M | 13.52%13.19M | 18.24%13.2M | 15.16%12.19M | 16.20%11.83M | 28.39%43.55M | 18.81%11.62M | 23.42%11.16M | 34.14%10.59M | 41.33%10.18M |
-Interest income from loans and lease | ---- | ---- | 13.33%9.72M | 17.36%9.47M | 20.95%9.24M | 33.62%33.35M | 28.21%9.07M | 31.23%8.57M | 37.75%8.07M | 39.05%7.64M |
-Interest income from securities | ---- | ---- | 4.75%2.36M | 7.99%2.39M | 7.71%2.33M | 16.00%8.92M | 6.36%2.29M | 8.74%2.25M | 20.37%2.22M | 33.05%2.17M |
-Other interest income | ---- | ---- | ---- | ---- | ---- | 0.47%1.27M | ---- | ---- | ---- | ---- |
-Total interest expense | 62.81%14.68M | 22.42%3.78M | 55.15%4.1M | 55.64%3.56M | 225.00%3.24M | 465.68%9.02M | 351.90%3.09M | 577.44%2.64M | 756.93%2.29M | 293.68%996K |
-Interest expense for deposit | ---- | ---- | 51.83%3.69M | 44.12%3.1M | 181.73%2.81M | 417.00%8.24M | 289.33%2.66M | 522.82%2.43M | 706.37%2.15M | 293.68%996K |
-Interest expense for long term debt and capital securities | ---- | ---- | 92.96%411K | 239.26%458K | --431K | --776K | --428K | --213K | --135K | ---- |
Non interest income | -0.44%7.66M | 4.60%1.93M | -7.02%1.83M | 9.23%2.05M | -4.55%1.91M | -3.26%7.69M | -5.18%1.85M | 4.63%1.97M | -4.82%1.87M | -6.97%2M |
-Total premiums earned | ---- | ---- | 0.00%47K | 0.00%66K | 6.67%48K | 2.49%206K | 9.09%48K | 6.82%47K | 4.76%66K | -10.00%45K |
-Fees and commissions | ---- | ---- | 2.19%1.78M | -0.69%1.73M | 0.30%1.67M | -2.21%6.89M | -4.99%1.75M | -5.33%1.74M | 0.64%1.74M | 1.40%1.66M |
-Other non interest income | 2,605.30%7.66M | 3,234.48%1.93M | -52.94%48K | 11.48%68K | 93.55%120K | 8.02%283K | -36.26%58K | 100.00%102K | 3.39%61K | 1.64%62K |
-Gain loss on sale of assets | ---- | ---- | -222.03%-72K | 8,250.00%163K | -70.85%65K | -39.38%254K | 27.78%-26K | 200.00%59K | -101.72%-2K | -43.97%223K |
-Dividend income | ---- | ---- | 50.00%27K | 118.18%24K | 9.09%12K | 163.64%58K | 125.00%18K | 260.00%18K | 175.00%11K | 120.00%11K |
Credit losses provision | -26.99%-1.45M | -12.34%-346K | -59.66%-463K | -2.86%-360K | -45.08%-280K | -20.11%-1.14M | 23.00%-308K | -65.71%-290K | -75.00%-350K | -10.29%-193K |
Non interest expense | 6.92%27.83M | 8.75%7.05M | 8.38%7.02M | 5.01%7M | 5.56%6.76M | 3.75%26.03M | 2.86%6.48M | -1.19%6.48M | 6.91%6.67M | 6.79%6.4M |
Occupancy and equipment | ---- | ---- | 9.43%476K | 7.62%480K | 3.58%463K | -4.19%1.76M | -4.41%434K | -5.84%435K | -2.19%446K | -4.28%447K |
Professional expense and contract services expense | ---- | ---- | 176.03%334K | 83.64%303K | 39.25%259K | -7.10%693K | 75.40%221K | -20.39%121K | -7.30%165K | -35.86%186K |
Selling and administrative expenses | ---- | ---- | 5.40%4M | 3.72%4.04M | 1.52%3.93M | 1.87%15.33M | -2.58%3.77M | -2.59%3.79M | 4.45%3.9M | 8.89%3.87M |
-General and administrative expense | ---- | ---- | 4.29%3.89M | 4.21%3.96M | 1.43%3.84M | 2.08%15M | -1.08%3.68M | -2.64%3.73M | 4.14%3.8M | 8.44%3.79M |
-Selling and marketing expense | ---- | ---- | 72.58%107K | -15.96%79K | 6.02%88K | -6.80%329K | -40.00%90K | 0.00%62K | 18.99%94K | 33.87%83K |
Other non-interest expense | ---- | ---- | 3.94%2.22M | 0.79%2.18M | 10.97%2.1M | 10.59%8.24M | 11.08%2.06M | 3.95%2.13M | 15.39%2.16M | 12.79%1.9M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | -5.86%14.17M | 9.97%3.95M | -7.41%3.44M | 5.10%3.32M | -24.54%3.46M | 5.73%15.05M | -17.39%3.59M | -2.21%3.71M | -0.06%3.16M | 56.59%4.59M |
Income tax | -1.42%2.22M | 43.10%684K | -6.12%537K | 13.75%488K | -34.07%507K | -3.10%2.25M | -40.55%478K | -14.50%572K | -4.03%429K | 92.25%769K |
Earnings from equity interest net of tax | ||||||||||
Net income | -6.64%11.95M | 4.88%3.27M | -7.64%2.9M | 3.74%2.83M | -22.62%2.96M | 7.45%12.8M | -12.14%3.11M | 0.42%3.14M | 0.59%2.73M | 50.95%3.82M |
Net Income continuous operations | -6.64%11.95M | 4.88%3.27M | -7.64%2.9M | 3.74%2.83M | -22.62%2.96M | 7.45%12.8M | -12.14%3.11M | 0.42%3.14M | 0.59%2.73M | 50.95%3.82M |
Minority interest income | 0.00%13K | 0.00%3K | 0.00%3K | 0.00%4K | 0.00%3K | 0.00%13K | 0.00%3K | 0.00%3K | 0.00%4K | 0.00%3K |
Net income attributable to the parent company | -6.65%11.94M | 4.89%3.26M | -7.65%2.9M | 3.74%2.83M | -22.64%2.95M | 7.46%12.79M | -12.15%3.11M | 0.42%3.14M | 0.59%2.73M | 51.01%3.82M |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | -6.65%11.94M | 4.89%3.26M | -7.65%2.9M | 3.74%2.83M | -22.64%2.95M | 7.46%12.79M | -12.15%3.11M | 0.42%3.14M | 0.59%2.73M | 51.01%3.82M |
Basic earnings per share | -6.54%3.57 | 4.30%0.97 | -7.45%0.87 | 3.66%0.85 | -22.81%0.88 | 7.61%3.82 | -12.26%0.93 | 1.08%0.94 | 1.23%0.82 | 52.00%1.14 |
Diluted earnings per share | -6.54%3.57 | 4.30%0.97 | -7.45%0.87 | 3.66%0.85 | -22.81%0.88 | 7.61%3.82 | -12.26%0.93 | 1.08%0.94 | 1.23%0.82 | 52.00%1.14 |
Dividend per share | 3.70%1.12 | 7.41%0.29 | 7.41%0.29 | 0.00%0.27 | 0.00%0.27 | 3.85%1.08 | 3.85%0.27 | 3.85%0.27 | 3.85%0.27 | 3.85%0.27 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |